$88.795
0.465[0.53%]
Last update: 12:46PM Get Real Time Here
Colgate-Palmolive
(NYSE:CL)Colgate-Palmolive Stock (NYSE:CL), Analyst Ratings, Price Targets, Predictions
Colgate-Palmolive Co has a consensus price target of $80.33, established from looking at the 73 latest analyst ratings. The last 3 analyst ratings were released from Citigroup, Barclays, and Stifel on April 16, 2024, April 12, 2024, and April 10, 2024. With an average price target of $92.67 between Citigroup, Barclays, and Stifel, there's an implied 3.94% upside for Colgate-Palmolive Co from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
Barclays
Stifel
Evercore ISI Group
Goldman Sachs
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Colgate-Palmolive
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/16/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | 12.17% | Citigroup | Filippo Falorni | $95 → $100 | Maintains | Buy | Get Alert |
| 04/12/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | -5.78% | Barclays | Lauren Lieberman | $82 → $84 | Maintains | Equal-Weight | Get Alert |
| 04/10/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | 5.44% | Stifel | Mark Astrachan | $89 → $94 | Maintains | Buy | Get Alert |
| 04/08/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | 7.68% | Evercore ISI Group | Robert Ottenstein | $90 → $96 | Maintains | Outperform | Get Alert |
| 03/01/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | 4.32% | Goldman Sachs | Jason English | → $93 | Reinstates | → Buy | Get Alert |
| 01/29/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | 4.32% | Morgan Stanley | Dara Mohsenian | $85 → $93 | Maintains | Overweight | Get Alert |
| 01/29/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | 6.56% | UBS | Peter Grom | $93 → $95 | Maintains | Buy | Get Alert |
| 01/29/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | -1.29% | Wells Fargo | Chris Carey | $80 → $88 | Maintains | Equal-Weight | Get Alert |
| 01/29/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | 2.08% | Raymond James | Olivia Tong | → $91 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/18/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | 0.95% | JP Morgan | Andrea Teixeira | $88 → $90 | Maintains | Overweight | Get Alert |
| 01/16/2024 | CL | Buy Now | Colgate-Palmolive | $89.15 | -8.02% | Barclays | Lauren Lieberman | $75 → $82 | Maintains | Equal-Weight | Get Alert |
| 12/15/2023 | CL | Buy Now | Colgate-Palmolive | $89.15 | 0.95% | B of A Securities | Bryan Spillane | → $90 | Upgrade | Neutral → Buy | Get Alert |
| 11/29/2023 | CL | Buy Now | Colgate-Palmolive | $89.15 | -1.29% | JP Morgan | Andrea Teixeira | $83 → $88 | Maintains | Overweight | Get Alert |
| 11/13/2023 | CL | Buy Now | Colgate-Palmolive | $89.15 | -2.41% | Jefferies | Kaumil Gajrawala | → $87 | Initiates | → Buy | Get Alert |
| 10/30/2023 | CL | Buy Now | Colgate-Palmolive | $89.15 | -10.26% | RBC Capital | Nik Modi | $79 → $80 | Maintains | Sector Perform | Get Alert |
| 10/30/2023 | CL | Buy Now | Colgate-Palmolive | $89.15 | -4.66% | Morgan Stanley | Dara Mohsenian | $89 → $85 | Maintains | Overweight | Get Alert |
| 10/17/2023 | CL | Buy Now | Colgate-Palmolive | $89.15 | -15.87% | B of A Securities | Bryan Spillane | $85 → $75 | Maintains | Neutral | Get Alert |
| 10/16/2023 | CL | Buy Now | Colgate-Palmolive | $89.15 | -9.14% | Stifel | Mark Astrachan | $85 → $81 | Upgrade | Hold → Buy | Get Alert |
| 10/12/2023 | CL | Buy Now | Colgate-Palmolive | $89.15 | -18.12% | Barclays | Lauren Lieberman | $81 → $73 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Colgate-Palmolive (CL)?
The latest price target for Colgate-Palmolive (NYSE: CL) was reported by Citigroup on April 16, 2024. The analyst firm set a price target for $100.00 expecting CL to rise to within 12 months (a possible 12.62% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Colgate-Palmolive (CL)?
The latest analyst rating for Colgate-Palmolive (NYSE: CL) was provided by Citigroup, and Colgate-Palmolive maintained their buy rating.
When was the last upgrade for Colgate-Palmolive (CL)?
The last upgrade for Colgate-Palmolive Co happened on January 29, 2024 when Raymond James raised their price target to $91. Raymond James previously had a market perform for Colgate-Palmolive Co.
When was the last downgrade for Colgate-Palmolive (CL)?
The last downgrade for Colgate-Palmolive Co happened on May 3, 2022 when Atlantic Equities changed their price target from $92 to $80 for Colgate-Palmolive Co.
When is the next analyst rating going to be posted or updated for Colgate-Palmolive (CL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Colgate-Palmolive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Colgate-Palmolive was filed on April 16, 2024 so you should expect the next rating to be made available sometime around April 16, 2025.
Is the Analyst Rating Colgate-Palmolive (CL) correct?
While ratings are subjective and will change, the latest Colgate-Palmolive (CL) rating was a maintained with a price target of $95.00 to $100.00. The current price Colgate-Palmolive (CL) is trading at is $88.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.